SCHEMBL6984237

SCHEMBL6984237

O=C(O)Oc1c(O)cccc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.48
CA1 P00915 7/20 0.48
CA12 O43570 6/20 0.48
CA14 Q9ULX7 6/20 0.48
CA7 P43166 5/20 0.48
CA9 Q16790 5/20 0.48
HPGD P15428 5/20 0.42
HSD17B10 Q99714 5/20 0.42
ALOX15 P16050 4/20 0.42
ALDH1A1 P00352 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 3/20 0.41
CA6 P23280 2/20 0.41
CA4 P22748 2/20 0.41
THRB P10828 1/20 0.41
HMGB1 P09429 1/20 0.41
NAPRT Q6XQN6 1/20 0.41
MAPT P10636 2/20 0.40
G6PD P11413 1/20 0.40
CASP7 P55210 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11780103 0.87 ESR1 (0.43) CA2CA1CA12CA14CA7
SCHEMBL29112120 0.85 ALDH1A1 (0.49) CA2CA1CA12CA14CA7
SCHEMBL11436114 0.82 GABRA1 (0.47) CA2CA1CA12CA14CA7
SCHEMBL7093557 0.78 KDM4E (0.52) CA2CA1CA12CA14CA7
SCHEMBL8579275 0.78 MAPT (0.61) CA2CA1CA12CA9HPGD
SCHEMBL9704212 0.76 PTGER4 (0.49) HPGDHSD17B10ALDH1A1THRBEGFR
SCHEMBL1462600 0.76 HSD17B10 (0.52) CA2CA1CA12CA14CA7
SCHEMBL1728306 0.75 MAPK1 (0.47) CA2CA1CA12CA14CA7
SCHEMBL31440643 0.75 TDP1 (0.48) CA2CA1CA12CA14CA7
Water SCHEMBL2704404 0.73 MAPK1 (0.46) CA2CA1CA12CA14CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP disclosed
US-5935973-A AFFINITY FOR 5-HT1A, ALPHA1, ALPHA2 AND/OR D2 RECEPTORS; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS, PSYCHOSES, DYSKINESIAS, PARKINSON'S DISEASE, HYPOTENSIVE AGENTS, TOURETTE'S SYNDROME, OBSESSIVE-COMPULSIVE BEHAVIOUR, PANIC ATTACKS, SOCIAL PHOBIAS KNOLL AKTIENGESELLSCHAFT (DE) 1999-08-10 US disclosed
EP-0839145-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP disclosed
WO-1997003071-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO disclosed
US-3987004-A CYCLIC CARBONATE, AMINE ANTIOXIDANT NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1976-10-19 US disclosed
US-3985705-A AGAINST THERMAL DEGRADATION NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1976-10-12 US disclosed